tirzepatide type 2 diabetes Peptide of the Week: Tirzepatide, a Game Changer for and Obesity Management Who Qualifies for Tirzepatide Medical

Peptides and proteins play an increasingly important role in the treatment of many diseases, but oral administration of peptides remains a challenge

Stimulant medications: High blood pressure, rapid heart rate, heart rhythm concerns, anxiety, and misuse risk

Older patients (especially those over 60) and those with preexisting cardiovascular disease benefit from lower GLP-1 starting doses, slower titration, and more frequent monitoring

Biohacker Protocol (experimental) Dose: 0.5 1 mg Duration: 6 8 weeks Frequency: 5 per week Cycle Interval: 4 weeks off before repeating Goal / Description: Low-dose continuous exposure for longevity and cellular preservation research